Publication: Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis
Issued Date
2006-11-01
Resource Type
ISSN
14766256
00029262
00029262
Other identifier(s)
2-s2.0-33750300013
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Epidemiology. Vol.164, No.9 (2006), 813-822
Suggested Citation
Ammarin Thakkinstian, Steve Bowe, Mark McEvoy, Wayne Smith, John Attia Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis. American Journal of Epidemiology. Vol.164, No.9 (2006), 813-822. doi:10.1093/aje/kwj279 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/23519
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis
Other Contributor(s)
Abstract
A possible association between apolipoprotein E polymorphisms and age-related macular degeneration has been investigated numerous times, with conflicting results. A previous analysis pooling results from four studies (Schmidt et al., Ophthalmic Genet 2002;23:209-23) suggested an association, but those investigators did not document allele frequencies, the magnitude of the association, or the possible genetic mode of action. Thus, the authors searched MEDLINE from 1966 to December 2005 for any English-language studies reporting genetic associations. Data and study quality were assessed in duplicate. Pooling was performed while checking for heterogeneity and publication bias. Frequencies of the E2and E4alleles in Caucasians were approximately 8% and 15%, respectively. Allele- and genotype-based tests of association indicated a risk effect of up to 20% for E2and a protective effect of up to 40% for E4. E2appeared to act in a recessive mode and E4in a dominant mode. There appears to be a differential effect of the E2and E4alleles on the risk of age-related macular degeneration, although the possibility of survivor bias needs to be ruled out more definitively. Copyright © 2006 by the Johns Hopkins Bloomberg School of Public Health. All rights reserved.
